About ACEA Biosciences
ACEA de Biosciences, a part of Agilent Technologies, is a pioneer in the development
and commercialization of high performance cell analysis platforms for life science
research. ACEA’s xCELLigence® Real-Time Cell Analysis instruments and
NovoCyte® Quanteon flow cytometers are used in pre-clinical drug discovery
and development, toxicology, safety pharmacology, and basic academic research. More
than 2,500 instruments have been placed globally, and have been used in more than
1,800 peer-reviewed publications. For more information visit www.aceabio.com.
About xCELLigence® Real Time Cell Analysis (RTCA)
ACEA Biosciences’ xCELLigence RTCA instruments are being used in both academia
and industry for life science applications ranging from cancer immunotherapy, bacterial
biofilms, vaccine development and cardiotoxicity testing. With the xCELLigence technology,
scientists can non-invasively monitor the behavior of cells by quantifying cell
proliferation, morphology change, and attachment quality in a label-free, real-time
manner.
About NovoCyte® Flow Cytometers
The NovoCyte® and Novocyte Quanteon™ are high performance benchtop flow
cytometers that are accessible to all levels of users. With one to three different
laser options and a highly customizable optical platform, the NovoCyte® can
be configured for diverse applications and is readily upgradeable over time. The
NovoCyte Quanteon™ flow cytometer builds upon its wildly successful predecessor,
the NovoCyte™, and provides an expanded set of capabilities that easily accommodate
the large, multi-color panels found in today’s highly progressive flow cytometry
laboratories. Scientists now have the flexibility to choose from 25 fluorescent
channels utilizing four lasers (405, 488, 561, and 637nm) with 25 independent silicon
photomultiplier (SiPM) detectors.
Read More